Kandu Health, Inc. and Neurolutions, Inc. announced on April 8 that the two companies have merged to form Kandu, Inc.
Founded in 2007, Neurolutions is a medical device company developing a platform of neurorehabilitation devices leveraging brain computer interface (BCI) technology. The company’s first product candidate, the IpsiHand Upper Extremity Rehabilitation System, or the IpsiHand System, is being developed for upper extremity rehabilitation in chronic stroke patients.
Kandu Health is a digital health company providing remote clinical support to stroke survivors and their care partners. The company was founded in 2021 and is based in Campbell, California.
“We are excited to bring together Neurolutions’ medical device expertise with the AI-supported digital health solutions of Kandu Health,” said Leo Petrossian, CEO of Neurolutions, who will lead the newly formed Kandu, Inc. as its CEO. “This merger positions Kandu, Inc. as a leader in the stroke recovery space and allows us to offer a seamless continuum of care, from the immediate post-acute phase through chronic rehabilitation and recovery. Kandu, Inc. is now able to offer a truly integrated care experience that aligns with the needs of stroke survivors, healthcare providers and caregivers.”
The newly formed company expects to set a new standard of care for stroke recovery, accessible to patients and caregivers at home, with a first-in-kind end-to-end solution for stroke survivors, combining BCI technology with personalized telehealth services.
According to data captured in the LevinPro HC database, this marks the 25th Medical Device transaction of 2025. There were 87 Medical Device acquisitions announced during 2024, 112 announced in 2023 and 124 announced during 2022.
